[Effects of 1 alpha-(OH)D3 on renal osteodystrophy--a 5-year retrospective evaluation].
D000284:Administration, Oral; D000328:Adult; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy* / Q000209:etiology; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects
D006887:Hydroxycholecalciferols; C008088:alfacalcidol